Stocktoria

Alpha Tau Medical Ltd. DRTS

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2022-03-08
Chart by TradingView
2/9
Piotroski F — financial health
-1.51
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Operating income-$42.3M-$36.0M-$35.7M-$32.1M-$13.8M
Net income-$42.6M-$31.8M-$29.2M-$33.8M-$27.3M
Operating cash flow-$26.7M-$19.8M-$18.0M-$23.9M-$11.8M
Free cash flow-$32.8M-$22.0M-$24.4M-$24.8M-$14.7M
Total assets$105.7M$86.2M$107.4M$120.1M$42.2M
Total liabilities$28.6M$23.5M$22.9M$14.5M$23.0M
Shareholders' equity$77.1M$62.7M$84.5M$105.7M-$34.8M
Ratios
Return on assets-40.3%-36.8%-27.2%-28.1%-64.6%
Return on equity-55.3%-50.7%-34.5%-32.0%78.4%
Current ratio7.457.4012.0724.557.41

Why these scores methodology →

Piotroski F-score: 2/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -1.51 (distress)

  • Working capital / assets 0.642
  • Retained earnings / assets -1.8
  • EBIT / assets -0.4
  • Equity / liabilities 2.7

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001871321 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.